Brain Tumor Radiogenomic Classification of O-Methylguanine-DNA Methyltransferase Promoter Methylation in Malignant Gliomas-Based Transfer Learning
Artificial Intelligence (AI) is the subject of a challenge and attention in the field of oncology and raises many promises for preventive diagnosis, but also fears, some of which are based on highly speculative visions for the classification and detection of tumors. A brain tumor that is malignant i...
Main Authors: | Houneida Sakly, Mourad Said, Jayne Seekins, Ramzi Guetari, Naoufel Kraiem, Mehrez Marzougui |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-04-01
|
Series: | Cancer Control |
Online Access: | https://doi.org/10.1177/10732748231169149 |
Similar Items
-
CoMod: An Abstractive Approach to Discourse Context Identification
by: Ramzi Guetari, et al.
Published: (2023-01-01) -
O-methylguanine-DNA methyltransferase (MGMT) mRNA expression predicts outcome in malignant glioma independent of MGMT promoter methylation.
by: Simone Kreth, et al.
Published: (2011-02-01) -
O6-Methylguanine-DNA Methyltransferase (MGMT): Challenges and New Opportunities in Glioma Chemotherapy
by: Wei Yu, et al.
Published: (2020-01-01) -
The evaluation of 06-methylguanine-DNA-methyltransferase (MGMT) gene methylation status among Hospital Universiti Sains Malaysia glioma patients
by: Murali, Revathy
Published: (2018) -
High-dose radiotherapy in newly diagnosed low-grade gliomas with nonmethylated O(6)-methylguanine-DNA methyltransferase
by: Yanwei Liu, et al.
Published: (2021-08-01)